Skip to content

Clinical trials

Keratoconus trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Keratoconus Phase: Not applicable Clear all

113 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20072
20085
20094
20104
201110
20123
20131
20144
20158
20168
20178
201811
201911
20204
20217
20225
20233
20245
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Unknown status31
Recruiting11
Terminated8
Not yet recruiting4
Active, not recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University4
Cornea and Laser Eye Institute3
Democritus University of Thrace3
Federal University of São Paulo3
Instituto de Oftalmología Fundación Conde de Valenciana3
Moorfields Eye Hospital NHS Foundation Trust3
Shahid Beheshti University3
Umeå University3
University Hospital, Toulouse3
University of Waterloo3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Keratoconus113
Corneal Diseases8
Dry Eye Syndromes5
Corneal Dystrophies, Hereditary4
Corneal Opacity4
Dilatation, Pathologic3
Eye Diseases3
Corneal Injuries2
Corneal Wavefront Aberration2
Glaucoma2

Trials

Showing 26 to 50 of 113. Each trial links to its page on Pharma Observatory.

13 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.